Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001093002 | SCV001249768 | uncertain significance | not provided | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001245742 | SCV001419047 | uncertain significance | Adrenoleukodystrophy | 2021-10-22 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with leucine at codon 70 of the ABCD1 protein (p.Val70Leu). The valine residue is moderately conserved and there is a small physicochemical difference between valine and leucine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has not been reported in the literature in individuals affected with ABCD1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV001245742 | SCV002045781 | uncertain significance | Adrenoleukodystrophy | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001093002 | SCV002504393 | likely benign | not provided | 2019-03-28 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Revvity Omics, |
RCV001093002 | SCV003824421 | uncertain significance | not provided | 2023-05-30 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001245742 | SCV002084594 | uncertain significance | Adrenoleukodystrophy | 2020-09-11 | no assertion criteria provided | clinical testing |